巨噬细胞来源外泌体通过递送抗纤维化miR-142-3p减轻气道上皮细胞纤维化
该研究纳入IPF患者与健康对照两个独立队列,检测痰和血浆外泌体miR表达,发现miR-142-3p在IPF患者痰和血浆中显著上调,且与痰巨噬细胞百分比正相关。体外实验表明miR-142-3p过表达可降低TGFβ-R1及促纤维化基因表达,巨噬细胞外泌体通过递送miR-142-3p发挥抗纤维化作用。
要点
- IPF患者痰和血浆外泌体miR-142-3p显著上调。
- 外泌体miR-142-3p与痰巨噬细胞百分比正相关。
- 巨噬细胞外泌体经miR-142-3p抑制TGFβ-R1发挥抗纤维化作用。
核心结论
- 巨噬细胞来源外泌体可能通过向肺泡上皮细胞和肺成纤维细胞递送抗纤维化miR-142-3p来对抗肺纤维化进展。
研究设计与样本
- 研究纳入两个独立队列:队列1为19例IPF患者和23名健康受试者的痰外泌体,队列2为14例IPF患者和14名健康受试者的血浆外泌体。
- 外泌体miR表达采用定量逆转录PCR检测,功能作用通过在人肺泡上皮细胞和肺成纤维细胞中转染miR模拟物进行体外评估。
主要发现
- 外泌体miR分析显示miR-142-3p在IPF患者痰中显著上调8.06倍(p<0.0001),在血浆中显著上调1.64倍(p=0.008)。
- 相关性分析显示外泌体miR-142-3p与IPF患者痰巨噬细胞百分比呈正相关(r=0.576,p=0.012),提示其上调的巨噬细胞来源。
- 在肺泡上皮细胞和肺成纤维细胞中过表达miR-142-3p可降低转化生长因子β受体1(TGFβ-R1)及促纤维化基因的表达。
- 从巨噬细胞分离的外泌体具有抗纤维化特性,部分归因于miR-142-3p转移至靶细胞后对TGFβ-R1的抑制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Idiopathic pulmonary fibrosis (IPF) is a progressive fibrosing interstitial lung disease of unknown aetiology and cure. Recent studies have reported a dysregulation of exosomal microRNAs (miRs) in the IPF context. However, the impact of IPF-related exosomal miRs on the progression of pulmonary fibrosis is unknown. METHODS: Two independent cohorts were enrolled at the ambulatory care polyclinic of Liège University. Exosomes from sputum were obtained from 19 patients with IPF and 23 healthy subjects (HSs) (cohort 1), and the ones from plasma derived from 14 patients with IPF and 14 HSs (cohort 2). Exosomal miR expression was performed by quantitative reverse transcription-PCR. The functional role of exosomal miRs was assessed in vitro by transfecting miR mimics in human alveolar epithelial cells and lung fibroblasts. RESULTS: Exosomal miR analysis showed that miR-142-3p was significantly upregulated in sputum and plasma of patients with IPF (8.06-fold, p<0.0001; 1.64 fold, p=0.008, respectively). Correlation analysis revealed a positive association between exosomal miR-142-3p and the percentage of macrophages from sputum of patients with IPF (r=0.576, p=0.012), suggesting macrophage origin of exosomal miR-142-3p upregulation. The overexpression of miR-142-3p in alveolar epithelial cells and lung fibroblasts was able to reduce the expression of transforming growth factor β receptor 1 (TGFβ-R1) and profibrotic genes. Furthermore, exosomes isolated from macrophages present antifibrotic properties due in part to the repression of TGFβ-R1 by miR-142-3p transfer in target cells. DISCUSSION: Our results suggest that macrophage-derived exosomes may fight against pulmonary fibrosis progression via the delivery of antifibrotic miR-142-3 p to alveolar epithelial cells and lung fibroblasts.
引用
- Guiot J, Cambier M, Boeckx A, et al. Macrophage-derived exosomes attenuate fibrosis in airway epithelial cells through delivery of antifibrotic miR-142-3p. Thorax. 2020. PMID: 32759383. doi:10.1136/thoraxjnl-2019-214077
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。